BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36317703)

  • 1. SOX10 modulated SMARCA4 dysregulation alleviates DNA replication stress in cutaneous melanoma.
    Fang X; Rao K; Wei Z; Cheng J
    J Cell Mol Med; 2022 Dec; 26(23):5846-5857. PubMed ID: 36317703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression.
    Marathe HG; Mehta G; Zhang X; Datar I; Mehrotra A; Yeung KC; de la Serna IL
    PLoS One; 2013; 8(7):e69037. PubMed ID: 23874858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.
    Laurette P; Coassolo S; Davidson G; Michel I; Gambi G; Yao W; Sohier P; Li M; Mengus G; Larue L; Davidson I
    Cell Death Differ; 2020 Jan; 27(1):29-43. PubMed ID: 31065107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRG1 interacts with SOX10 to establish the melanocyte lineage and to promote differentiation.
    Marathe HG; Watkins-Chow DE; Weider M; Hoffmann A; Mehta G; Trivedi A; Aras S; Basuroy T; Mehrotra A; Bennett DC; Wegner M; Pavan WJ; de la Serna IL
    Nucleic Acids Res; 2017 Jun; 45(11):6442-6458. PubMed ID: 28431046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
    Wilson BG; Helming KC; Wang X; Kim Y; Vazquez F; Jagani Z; Hahn WC; Roberts CW
    Mol Cell Biol; 2014 Mar; 34(6):1136-44. PubMed ID: 24421395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.
    Saladi SV; Keenen B; Marathe HG; Qi H; Chin KV; de la Serna IL
    Mol Cancer; 2010 Oct; 9():280. PubMed ID: 20969766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
    Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
    J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers.
    Peng L; Li J; Wu J; Xu B; Wang Z; Giamas G; Stebbing J; Yu Z
    Front Immunol; 2021; 12():762598. PubMed ID: 34675941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
    Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
    J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer.
    Giles KA; Gould CM; Achinger-Kawecka J; Page SG; Kafer GR; Rogers S; Luu PL; Cesare AJ; Clark SJ; Taberlay PC
    Clin Epigenetics; 2021 Feb; 13(1):37. PubMed ID: 33596994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MITF-independent pro-survival role of BRG1-containing SWI/SNF complex in melanoma cells.
    Ondrušová L; Vachtenheim J; Réda J; Záková P; Benková K
    PLoS One; 2013; 8(1):e54110. PubMed ID: 23349796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switch/sucrose-non-fermentable (SWI/SNF) complex (SMARCA4, SMARCA2, INI1/SMARCB1)-deficient colorectal carcinomas are strongly associated with microsatellite instability: an incidence study in 4508 colorectal carcinomas.
    Ahadi MS; Fuchs TL; Clarkson A; Sheen A; Sioson L; Chou A; Gill AJ
    Histopathology; 2022 May; 80(6):906-921. PubMed ID: 34951482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ATPase BRG1/SMARCA4 is a protein interaction platform that recruits BAF subunits and the transcriptional repressor REST/NRSF in neural progenitor cells.
    Jayaprakash S; Drakulic S; Zhao Z; Sander B; Golas MM
    Mol Cell Biochem; 2019 Nov; 461(1-2):171-182. PubMed ID: 31428904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of BRG1 in Antioxidant and Redox Signaling.
    You S; Zhang Y; Xu J; Qian H; Wu S; Wu B; Lu S; Sun Y; Zhang N
    Oxid Med Cell Longev; 2020; 2020():6095673. PubMed ID: 33014273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4.
    Mo Y; Duan S; Zhang X; Hua X; Zhou H; Wei HJ; Watanabe J; McQuillan N; Su Z; Gu W; Wu CC; Vakoc CR; Hashizume R; Chang K; Zhang Z
    Cancer Discov; 2022 Dec; 12(12):2906-2929. PubMed ID: 36305747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA CPS1-IT1 suppresses melanoma cell metastasis through inhibiting Cyr61 via competitively binding to BRG1.
    Zhou X; Rao Y; Sun Q; Liu Y; Chen J; Bu W
    J Cell Physiol; 2019 Dec; 234(12):22017-22027. PubMed ID: 31111478
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Concepcion CP; Ma S; LaFave LM; Bhutkar A; Liu M; DeAngelo LP; Kim JY; Del Priore I; Schoenfeld AJ; Miller M; Kartha VK; Westcott PMK; Sánchez-Rivera FJ; Meli K; Gupta M; Bronson RT; Riely GJ; Rekhtman N; Rudin CM; Kim CF; Regev A; Buenrostro JD; Jacks T
    Cancer Discov; 2022 Feb; 12(2):562-585. PubMed ID: 34561242
    [No Abstract]   [Full Text] [Related]  

  • 19. High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.
    Guerrero-Martínez JA; Reyes JC
    Sci Rep; 2018 Feb; 8(1):2043. PubMed ID: 29391527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression inactivation of SMARCA4 by microRNAs in lung tumors.
    Coira IF; Rufino-Palomares EE; Romero OA; Peinado P; Metheetrairut C; Boyero-Corral L; Carretero J; Farez-Vidal E; Cuadros M; Reyes-Zurita FJ; Lupiáñez JA; Sánchez-Cespedes M; Slack FJ; Medina PP
    Hum Mol Genet; 2015 Mar; 24(5):1400-9. PubMed ID: 25355421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.